The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Insulet Flags Dosing Defect in Some Omnipod Devices, Sees Up to $50 Million Cost

Insulet said on Tuesday it is carrying out a voluntary correction of certain insulin pump ⁠pods across its Omnipod product lines after identifying a manufacturing issue that...

Canada, Bahamas Imposes Ebola-related Travel Bans

Canada and the Bahamas said on Tuesday they will temporarily ban residents from the ⁠Democratic Republic of the Congo, Uganda and South Sudan amid an Ebola outbreak.

US Planning Quarantine Facility in Kenya for Citizens Exposed to Ebola, Sources Say

The U.S. is discussing with Kenya opening a facility there to quarantine American citizens who become exposed to the Ebola outbreak centered in the Democratic Republic of...

Impact of US Population Aging on Hospital Medicine

As Americans get older, the impact often lands on hospitalists and hospitals.

New Case in Spain Brings Hantavirus Cases From Outbreak to 13

The number of cases of ⁠Hantavirus linked to a cruise ship at the centre of an ⁠outbreak has increased to 13, according to the head of the WHO.

Prevalence of Tree Nut Allergies in Dutch Children

The prevalence of tree nut allergies is nearly 6% in Dutch children aged 1-12 years, with fewer than 1 in 4 introduced to tree nuts before 12 months of age.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Latest News

Insulet said on Tuesday it is carrying out a voluntary correction of certain insulin pump ⁠pods across its Omnipod product lines after identifying a manufacturing issue that...

Canada and the Bahamas said on Tuesday they will temporarily ban residents from the ⁠Democratic Republic of the Congo, Uganda and South Sudan amid an Ebola outbreak.

The U.S. is discussing with Kenya opening a facility there to quarantine American citizens who become exposed to the Ebola outbreak centered in the Democratic Republic of...

As Americans get older, the impact often lands on hospitalists and hospitals.

The number of cases of ⁠Hantavirus linked to a cruise ship at the centre of an ⁠outbreak has increased to 13, according to the head of the WHO.

The prevalence of tree nut allergies is nearly 6% in Dutch children aged 1-12 years, with fewer than 1 in 4 introduced to tree nuts before 12 months of age.

News All Time

MR Metformin and SGLT2i Now First-Line in Type 2 Diabetes

Clinicians at the Primary Care Show discuss what revised NICE guidance means for type 2 diabetes management in practice.

Andes Virus Debate: Could Airborne Spread Play a Role?

Recent outbreaks and cruise ship exposures are renewing the debate over whether current Andes virus precautions adequately address possible respiratory spread.

What’s in the Axial Spondyloarthritis Treatment Pipeline?

Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.

US Survey Finds Sunburn Reports Common, Even With Sunscreen

More than one third of US adults in the 2024 National Health Interview Survey report experiencing at least one sunburn.

Ontario Opts to Expand Pharmacists’ Scope of Practice

Patients in the province will be able to seek care at pharmacies for conditions like head lice, nasal congestion, dry eye, and ringworm.

Moxifloxacin Outperforms Azithromycin in M genitalium Cure

A 10-day course of moxifloxacin 400 mg once daily demonstrates superior efficacy to a 6-day course of azithromycin 500 mg once daily for treating Mycoplasma genitalium infection.

Belimumab Linked to Lower Relapse Risk in Lupus Serositis

Despite the initial response rate to anti-inflammatory therapy in patients with systemic lupus erythematosus with serositis, relapses remain common; belimumab is linked to a lower risk for relapse.

mRNA Works Differently Than We Thought (and That’s Good)

The safety of approved mRNA vaccines is not in question, but details of their underlying biology are being revealed that could lead to better drugs.

Extended Low eGFR Time Tied to More Youth Kidney Transplants

Longer time with low estimated glomerular filtration rate increases the likelihood of preemptive and living donor kidney transplants in youth, though disparities persist by race.

US Ebola Patient in Berlin Hospital Not Critically Ill, Family Tests Negative

A U.S. citizen who contracted Ebola in the Democratic Republic of Congo, ⁠where an outbreak of a rare strain has killed over 130 people, is not ⁠critically ill and his wife...

Early Childhood Screening for Type 1 Diabetes May Be Beneficial for Patients

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)

Sleep Disordered Breathing and Cardiovascular Disease

Whether sleep disordered breathing is part of the pathophysiology of CVD or vice versa has been an ongoing debate.

COVID Linked to Lasting Eye Problems

Individuals who have had COVID, especially severe cases, may face a higher long-term risk for eye problems, a recent study shows.

Acting Head of US NIH Infectious Disease Institute Has Left, Senators Say

The acting director of the U.S. NIH's infectious disease institute has stepped down, two Democratic senators said on Thursday during a Senate hearing, ⁠even as the United...

Obesity-Related Asthma: Is Inflammation Driving Severity?

Emerging evidence suggests that leptin, dysbiosis, and altered innate immunity may contribute to poor asthma control in patients with obesity.

Earlier Melanoma Dx Seen in Regions With More Dermatologists

Higher dermatologist density is associated with lower proportions of late stage melanoma diagnosis across US health service areas, a study finds.

Recommended News For You

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Is Vitamin D a Key to Better Breast Cancer Survival?

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

Why are so many young adults getting cancer?

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

A prostate cancer risk prediction algorithm could help target men at highest risk

Recommended Articles For You

Respiratory Ramifications of Systemic Disease: A Comprehensive Review 

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure  

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung cancer screening adherence rates decline annually after baseline screening

2.

MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA

3.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

4.

World's premier cancer institute faces crippling cuts and chaos

5.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

1.

The Power of Romiplostim in Treating Low Platelet Counts 

2.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

3.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

4.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

5.

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot